Today, the Province of BC announced $2 million in funding for the Michael Cuccione Foundation to support the Michael Cuccione Childhood Cancer Research Program at BC Children’s Hospital.
These funds will expand access for B.C. children with leukemia to clinical trials for the specialized cancer treatment CAR-T cell therapy.
CAR-T cell therapy uses a patient’s own immune cells to attack and eradicate leukemia cells. The research program will focus on continuing clinical trials and research into childhood-cancer, including better understanding childhood cancers and seeking new therapies with lower side-effects for young patients.
Read the Ministry of Health news release to learn more.